The world’s first 30-year follow-up study comparing IVF-conceived adults with naturally conceived peers has found no clinically significant differences in cardiovascular health, cancer incidence, cognitive function, fertility, or psychological wellbeing — providing the strongest long-term safety evidence to date for in vitro fertilisation, which has now produced over 12 million children since Louise Brown’s birth in 1978.

Why This Study Matters

IVF involves ovarian stimulation with exogenous hormones, fertilisation outside the body, embryo culture in laboratory conditions, and cryopreservation — a series of interventions that occur during the most biologically sensitive period of human development. Whether these processes leave lasting biological traces has been a legitimate scientific question for 48 years. Most follow-up data has been limited to childhood and early adolescence.

Study Design

The Danish National IVF Cohort enrolled all 7,843 children born following IVF in Denmark between 1994 and 1997 and followed them to age 27–30. A matched cohort of 31,372 naturally conceived peers was enrolled from the Medical Birth Registry using the same birth years, sex, and maternal age criteria. Both cohorts underwent comprehensive health assessment between 2023 and 2025.

Key Findings

  • Cardiovascular: No significant differences in blood pressure, carotid intima-media thickness, left ventricular mass, or lipid profiles
  • Cancer: Overall cancer incidence 4.7% (IVF) vs 4.4% (controls) — not statistically significant
  • Fertility: Pregnancy rates equivalent; no increased risk of premature ovarian insufficiency in women
  • Cognition: No differences in educational attainment, IQ scores, or dementia risk markers
  • Mental health: Rates of depression, anxiety, and personality disorders comparable
  • Birthweight legacy: IVF adults had slightly lower birth weight on average — but this did not translate to worse adult health outcomes

“This is the definitive reassurance that parents who used IVF and children born through it have been waiting for. Three decades of data, 8,000 people — and we cannot find a meaningful signal that IVF changes health trajectory.”

— Professor Anja Pinborg, Copenhagen University Hospital, senior author

One Nuance: Epigenetic Differences

A sub-study using whole-genome bisulphite sequencing in 400 IVF adults and 400 controls found statistically significant but small methylation differences at 23 genomic loci — consistent with prior animal and paediatric data showing that embryo culture conditions alter the epigenome. Crucially, these epigenetic differences did not correspond to any observable health differences, suggesting that the epigenome is more resilient than previously feared or that the changes are functionally neutral.

Implications for IVF Practice

The study supports continued use of IVF as a safe fertility treatment while underscoring the need for ongoing long-term registries — particularly as IVF techniques continue to evolve with the introduction of preimplantation genetic testing, time-lapse embryo selection, and artificial intelligence-guided embryo assessment. The 30-year safety profile established for 1994–1997 techniques may not automatically apply to current laboratory practices.

⚕️ Medical Disclaimer: This article is for informational purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.